24 May 2013
Keywords: merck, gets, zocor, patent, extension, co, been
Article | 11 March 2002
Merck & Co has been granted an additional six months of US patentprotection for its lipid-lowering drug Zocor (simvastatin) in return ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.